Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
SARASOTA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments...
Brain
ImmuneSensor Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead cGAS Inhibitor Drug Candidate, IMSB301
Safety, pharmacokinetics and target engagement data from first-in-human Phase 1 clinical trial in healthy volunteers will potentially enable rapid advancement...
Borvo Medical Announces U.S. FDA 510(k) Clearance for Innovative Surgical Device, Offering a Minimally Invasive Option for Surgical Brain Treatment
Borvo EVAC™ System Provides Advanced Approach for the Growing Number of PatientsRequiring Subdural Hematoma (SDH) Drainage Driven by Factors Such...
Diagonal Therapeutics to Present at the Cure HHT’s 15th International Scientific Conference
Diagonal is advancing its lead program to treat the underlying cause of hereditary hemorrhagic telangiectasia (HHT)WATERTOWN, Mass., Oct. 08, 2024...
IRLAB Receives Milestone Payment of USD 2.5 million in Conjunction with First Dosing in a Phase I Study with IRL757 in Healthy Older Adults
GOTHENBURG, SWEDEN / ACCESSWIRE / October 8, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company...
Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical
SAN MATEO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated...
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million...
Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries
ISTANBUL and LONDON, and BOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the...
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024
GT-02287 Demonstrates Disease Modifying Capacity in Both GBA1 and Idiopathic Parkinson’s Disease Models GT-02287 Improves Mitochondrial Function and Provides Neuroprotective...
Brain Computer Interface (BCI) Market is expected to generate a revenue of USD 10.86 Billion by 2031, Globally, at 14.61% CAGR: Verified Market Research®
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its...
Neurotech is Changing the Way We Treat Disease and Understand the Brain; Are Our Medical and Legal Institutions Ready?
The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical,...
Aero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery Applications
Now available for licensing, Ultra Soft Nasal Pump Spray leverages innovative spray nozzle chip technology for superior nasal cavity coverage...
Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma
October 4, 2024 Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent...
Host Defense® Launches Long-Awaited BrainPower Stack™ Powder!
OLYMPIA, Wash. , Oct. 3, 2024 /PRNewswire/ -- Industry leader Fungi Perfecti, LLC – makers of Host Defense® Mushrooms™ introduces BrainPower...
Epsom Salt Council Sponsors the Maui Calm Project – A Float Therapy Initiative Aimed at Providing Stress and Anxiety Relief to Survivors of the 2023 Maui Wildfires
CHARLOTTE, NC / ACCESSWIRE / October 3, 2024 / Epsom Salt Council, an organization dedicated to raising awareness about the...
Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases
NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Annovis Bio Inc. (NYSE: ANVS) announces the availability of a broadcast...
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
New products complement an already extensive range of products enabling fundamental advancements in neuroscience researchHOLLISTON, Mass., Oct. 03, 2024 (GLOBE...
Positive Data from the First Part of IRLAB’s Phase I Study with the Drug Candidate IRL757
GOTHENBURG, SE / ACCESSWIRE / October 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 3 2024 - IRLAB Therapeutics...
Gut Microbiome Health Tech Innovator, Ixcela Launches Virtual Clinic to Ease Cancer Symptoms After Landmark Roper St. Francis Healthcare Pilot
Gut Microbiome Health Plays Critical Role Reducing Cancer Care Side Effects including Fatigue, Brain Fog, Nausea, Constipation, Sleep and Overall...
Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Annovis Bio Inc. (NYSE: ANVS) today announces its placement...